Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Viennese start-up carries out research on drug to fight tuberculosis

"We are beginning with tuberculosis", the CEO added. The California-based biotech company Trianni Inc. which Wabl established a few years ago has ensured the necessary pre-requisites for this. “The main problem is the resistance against antibiotics, but there is an alternative, namely antibodies”, said the trained chemist and biologist, who teaches microbiology and immunology at the American university. Trianni created the platform enabling the antibodies to be identified. This means genetic mice developed for this purpose. In addition to various pharmaceutical companies, Austrianni is one of the licensees of the patented antibody platform and can continue researching on this basis. The mice mentioned above produce the humanized antibodies needed to fight tuberculosis and other diseases.

The business location decision of Austrianni was not only based on the roots of the company’s founder in Austria. „There are very generous funding possibilities here. This is one of the main reasons“, Wabl added. Up to 70 percent of the project costs can be contributed by the Austrian Research Promotion Agency FFG. Moreover, Austria “is making great efforts to expand its biotech sector”, Wabl concluded.

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Expand to Austria

    26.06.2019, Brescia, Italy

  • Research Dialogue with Summery Jazz Sounds

    02.07.2019, Stuttgart, Germany

Austria Map

Find the perfect location for your company

Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!

Pfizer

Logo
More testimonials

news from the business location Austria

Ottobock invests EUR 2 million in Vienna

The underlying basis of success of the globally recognised development work of the German life sciences company Ottobock being carried out in Vienna is the extremely pronounced medical research landscape offering fertile ground for interdisciplinary R&D projects.

Innovations from Austria for the Logistics Sector

At the present time there are many influencing factors which pose challenges to the supply chain and logistics management. Solutions in this area are frequently developed by startups, also from Austria. Several of them will present their innovations at the Austrian Logistics Day and Logistics Future Lab.

More news All blog posts